Kaida BioPharma Inc. — Form D
Kaida BioPharma Inc. of FORT LAUDERDALE, FL, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-21. The offering totals $3.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-21
- Form: D
- Accession: 0001493152-26-003028
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.6M
- Remaining: $1.4M
- Investors: 42
- Date of first sale: 2023-10-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-570572
Issuer
- Name: Kaida BioPharma Inc.
- CIK: 0001973954
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 416 SW 1ST AVENUE, FORT LAUDERDALE, FL, 33301
- Phone: (917) 683-3092
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Stella Vnook | Director | Kenmore, NY |
| Stephen Dunn | Director | Fort Lauderdale, FL |
| Craig Pierson | Director | Fort Lauderdale, FL |
| Craig Pierson | Executive Officer | Fort Lauderdale, FL |
Other filings by this issuer (1)
More